Financial Architects (New Jersey)’s Celgene Corporation Contingent Value Rights CELGZ Stock Holding History

Financial Architects (New Jersey)’s Portfolio CELGZ Stock Details CELGZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-450	Closed	-$1K	–	1687
2017 Q2	$1K	Hold	450	–	–	﹤0.01%	1501
2017 Q1	$0	Hold	450	–	–	﹤0.01%	1683
2016 Q4	$0	Hold	450	–	–	﹤0.01%	1574
2016 Q3	$0	Hold	450	–	–	﹤0.01%	1551
2016 Q2	$1K	Hold	450	–	–	﹤0.01%	1423
2016 Q1	$1K	Buy	+450	New	+$602	﹤0.01%	1159
2013 Q4	–	Sell	-36,900	Closed	-$297K	–	725
2013 Q3	$297K	Hold	36,900	–	–	0.19%	95
2013 Q2	$270K	Buy	+36,900	New	+$268K	0.2%	93

Other funds holding CELGZ

Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return

Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return

FCG Advisors Chatham, New Jersey $425M AUM 12.09% 1-Year Est. Return

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

MSTVIM

Messner & Smith Theme Value Investment Management San Diego, California $60.3M AUM 16.8% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return

CSS LLC Chicago, Illinois $2.57B AUM 67.1% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

First Manhattan New York $39.2B AUM 21.04% 1-Year Est. Return

Financial Architects (New Jersey)'s CELGZ Position: Q3 2017 in Review

Financial Architects (New Jersey) sold out of Celgene Corporation Contingent Value Rights (CELGZ) in Q3 2017, closing a stake of 450 shares — an estimated $1K sold.

Financial Architects (New Jersey) first reported a position in CELGZ in Q2 2013 and held it in 8 quarters. The position peaked at $297K in Q3 2013. 19 funds tracked by Wall St. Rank hold CELGZ as of Q3 2017.

Financial Architects (New Jersey) reported no remaining Celgene Corporation Contingent Value Rights position as of Q3 2017 after selling out during the quarter.
Financial Architects (New Jersey) sold 450 Celgene Corporation Contingent Value Rights shares in Q3 2017, an estimated $1K.
Financial Architects (New Jersey) first reported a position in Celgene Corporation Contingent Value Rights in Q2 2013 and held it in 8 quarters.
Financial Architects (New Jersey)'s Celgene Corporation Contingent Value Rights position peaked at $297K in Q3 2013.
19 funds tracked by Wall St. Rank held Celgene Corporation Contingent Value Rights as of Q3 2017.

Based on Financial Architects (New Jersey)'s 13F filing for Q3 2017, filed 23 Oct 2017.